惠伦晶体(300460) - 2020 Q1 - 季度财报

Financial Performance - Total revenue for Q1 2020 was ¥40,878,129.05, a decrease of 4.21% compared to ¥42,675,783.09 in the same period last year[7] - Net profit attributable to shareholders was -¥7,749,265.58, improving by 38.09% from -¥12,517,615.41 year-on-year[7] - Basic earnings per share were -¥0.0461, a decrease of 37.84% compared to -¥0.074 in the same period last year[7] - The company reported a net loss of 7.75 million yuan for the first quarter of 2020, a 38.09% increase in loss compared to the same period last year[16] - Operating revenue for the first quarter was 40.88 million yuan, a decrease of 4.21% year-on-year[16] - The net loss for Q1 2020 was CNY 7,749,265.58, an improvement compared to a net loss of CNY 12,517,615.41 in the same period last year[39] - The basic and diluted earnings per share for Q1 2020 were both -0.0461, compared to -0.074 in the previous year[40] - The company reported an operating profit of -9,058,553.33, an improvement from -12,538,563.26 in the previous period[39] - The total comprehensive income for the first quarter was -3,781,480.04 CNY, compared to -8,337,154.95 CNY in the previous period, indicating an improvement[44] Cash Flow and Liquidity - Net cash flow from operating activities was ¥344,606.15, down 85.37% from ¥2,355,719.96 in the previous year[7] - Cash and cash equivalents decreased by 64.96% from the beginning of the year, primarily due to payments for equipment procurement[14] - The cash flow from operating activities decreased by 85.37% compared to the same period last year, primarily due to increased payments for goods and taxes[15] - Cash inflow from operating activities amounted to 79,902,909.50 CNY, up from 57,758,612.87 CNY in the previous period, reflecting a growth of approximately 38.3%[46] - The net cash flow from operating activities was 344,606.15 CNY, a significant decrease from 2,355,719.96 CNY in the previous period[47] - Cash outflow for purchasing goods and services was 45,483,493.33 CNY, compared to 32,640,125.97 CNY in the previous period, representing an increase of approximately 39.3%[47] - The net cash flow from investing activities was -36,411,430.02 CNY, worsening from -2,531,821.73 CNY in the previous period[48] - Cash inflow from financing activities was 13,000,000.00 CNY, down from 15,633,840.59 CNY in the previous period[48] - The net cash flow from financing activities was 7,385,263.34 CNY, a recovery from -30,255,056.66 CNY in the previous period[48] - The ending cash and cash equivalents balance was 15,488,599.53 CNY, down from 34,289,304.40 CNY in the previous period[48] Assets and Liabilities - Total assets at the end of the reporting period were ¥824,283,752.02, an increase of 2.27% from ¥805,957,053.72 at the end of the previous year[7] - Current assets decreased slightly to CNY 396,602,086.45 from CNY 402,399,014.88, a decline of about 1.9%[29] - Inventory increased significantly to CNY 174,808,552.35, up from CNY 139,826,007.66, marking a rise of approximately 25%[29] - Total liabilities increased to CNY 308,645,817.16 from CNY 282,569,853.28, representing a growth of approximately 9.2%[31] - The company's equity decreased to CNY 515,637,934.86 from CNY 523,387,200.44, a decline of about 1.5%[32] - Total current liabilities were CNY 237,170,785.41, while total liabilities stood at CNY 282,569,853.28[55] - Total liabilities rose to CNY 325,290,890.30 from CNY 296,014,023.67, reflecting increased financial obligations[38] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 18,114[10] - The largest shareholder, Xinjiang Huilun Equity Investment Partnership, held 30.60% of the shares, totaling 51,493,557 shares[10] - The company did not engage in any repurchase transactions among the top 10 shareholders during the reporting period[11] Government Support and Market Conditions - The company received government subsidies amounting to ¥364,141.27, with a net impact of ¥309,520.08 after tax considerations[8] - The ongoing COVID-19 pandemic poses risks to raw material supply, market demand, and production capabilities, which the company is actively addressing[19] - The company plans to localize the procurement of key raw materials to mitigate risks associated with supply chain disruptions due to the pandemic[20] Research and Development - Research and development expenses increased to CNY 5,746,700.00 from CNY 4,963,113.98, indicating a focus on innovation[38] Accounting Changes - The first quarter report for 2020 was not audited, which may affect the reliability of the financial data presented[59] - The company has adopted new revenue and lease standards starting in 2020, which may impact future financial reporting[58]